Overview

Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders

Status:
Unknown status

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

This study is a prospective, multicenter, randomized, placebo-controlled clinical trial, to evaluate impact of Triptolide wilfordii on T cell immune activation and inflammation biomarkers in HIV-infected immunological non-responders.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

LI Taisheng

Treatments:

Triptolide